Area of research
Rheumatology · Surgery
Research interest
Research interests include Medicine, Internal medicine, Hypereosinophilia, Hypereosinophilic syndrome, Immunology, and Gastroenterology.
IRF4 haploinsufficiency in a multiplex family with Whipple’s disease
Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity
French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes
Multicenter Retrospective Analysis of Eosinophilic Myeloid Neoplasms
Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5
Vascular Endothelial Damage in the Pathogenesis of Organ Injury in Severe COVID-19
Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study
Endotheliopathy Is Induced by Plasma From Critically Ill Patients and Associated With Organ Failure in Severe COVID-19
Epidemiology, clinical picture and long‐term outcomes of<i>FIP1L1‐PDGFRA</i>‐positive myeloid neoplasm with eosinophilia: Data from 151 patients
Systematic retrospective study of 64 patients with anti-Mi2 dermatomyositis: A classic skin rash with a necrotizing myositis and high risk of malignancy
Digestive-tract sarcoidosis
Defining normality in a European multinational cohort: Critical factors influencing the 99th percentile upper reference limit for high sensitivity cardiac troponin I
CD3-CD4+ lymphoid variant of hypereosinophilic syndrome: nodal and extranodal histopathological and immunophenotypic features of a peripheral indolent clonal T-cell lymphoproliferative disorder
European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay
Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies
The Lymphoid Variant of Hypereosinophilic Syndrome
Inflammation and Disease Activity are Associated with High Circulating Cardiac Markers in Rheumatoid Arthritis Independently of Traditional Cardiovascular Risk Factors